Mdxhealth Sa ADR (MDXH)

$4.81 +0.03 (0.63%)
Market Cap 227.46M
Revenue (ttm) 90.05M
Net Income (ttm) -38.07M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -42.28%
Debt to Equity Ratio -85.98
Volume 153,200
Avg Vol 162,922
Day's Range N/A - N/A
Shares Out 47.29M
Stochastic %K 86%
Beta 1.65
Analysts Strong Sell
Price Target $6.50

Company Profile

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. The company's testing solutions include Select mdx, a non-invasive urine test for prostate cancer that measures the expression of two mRNA cancer-related biomarkers; Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; and Resolve...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: (866) 259-5644
Address:
CAP Business Center, Rue d’Abhooz 31 Zone Industrielle des Hauts-Sarts, Herstal, Belgium
livingthehilife
livingthehilife Oct. 3 at 5:08 PM
$SES 🧨 : Super low float under 50 million outstanding shares $MDXH a little more volume, and this thing will explode : $SPY
0 · Reply
NVDAMillionaire
NVDAMillionaire Oct. 2 at 6:17 AM
$MDXH Brilliant piece that captures MDXH's situation perfectly. So if you want to update your understanding of MDXH or get to know MDXH better, this is essential reading. https://beyondspx.com/quote/MDXH/analysis/mdxhealth-mdxh-unlocking-growth-in-urology-diagnostics-with-precision-technology
0 · Reply
slick3333
slick3333 Sep. 27 at 2:13 AM
$MDXH cant lie I was impressed with the recovery today!!
0 · Reply
Lukumon
Lukumon Sep. 26 at 6:02 PM
$MDXH $5 soon.
0 · Reply
highnihilism
highnihilism Sep. 25 at 12:36 PM
Volume (Relative to 90-Day Average) → $ADVM Adverum Biotechnologies × 2.7 $MDXH MdXHealth × 1.7 $IONR Ioneer × 12.8 $RICH Rchtech Robotics × 2.4 $TROX Tronox × 1.8
0 · Reply
slick3333
slick3333 Sep. 23 at 2:32 PM
$MDXH bummer it was a nice run while it lasted ….was hoping we crossed 5 before the dump oh well…..
2 · Reply
livingthehilife
livingthehilife Sep. 23 at 1:45 PM
$MDXH A push 2 5 Super low flot : $SPY
0 · Reply
slick3333
slick3333 Sep. 22 at 7:41 PM
$MDXH 3x normal volume what the volume is going on!
0 · Reply
thecontracap
thecontracap Sep. 22 at 3:25 PM
$MDXH 3.5x rev is $8. $4X rev is $9.50. $VCYT grows half as fast and trades 4.5x.
1 · Reply
livingthehilife
livingthehilife Sep. 22 at 2:46 PM
$MDXH : Super love float : $SPY
0 · Reply
Latest News on MDXH
Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne

Aug 5, 2025, 4:01 PM EDT - 2 months ago

Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne

Mdxhealth Appoints Michael Holder to Board of Directors and Announces Management Change

Jul 3, 2025, 1:00 PM EDT - 3 months ago

Mdxhealth Appoints Michael Holder to Board of Directors and Announces Management Change

MDxHealth SA (MDXH) Q1 2025 Earnings Call Transcript

May 14, 2025, 9:57 PM EDT - 5 months ago

MDxHealth SA (MDXH) Q1 2025 Earnings Call Transcript

MDxHealth Reports Q1-2025 Results

May 14, 2025, 4:00 PM EDT - 5 months ago

MDxHealth Reports Q1-2025 Results

MDxHealth SA (MDXH) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 8:57 PM EST - 7 months ago

MDxHealth SA (MDXH) Q4 2024 Earnings Call Transcript

Mdxhealth Announces Fourth Quarter and Full-Year 2024 Financial Results

Feb 26, 2025, 4:00 PM EST - 7 months ago

Mdxhealth Announces Fourth Quarter and Full-Year 2024 Financial Results

MDxHealth Reports Preliminary Fourth Quarter and Full Year 2024 Revenues and Issues 2025 Revenue Guidance

Jan 13, 2025, 5:00 AM EST - 9 months ago

MDxHealth Reports Preliminary Fourth Quarter and Full Year 2024 Revenues and Issues 2025 Revenue Guidance

MDxHealth: Strong Buy On Its Cutting-Edge Urology Diagnostics

Dec 13, 2024, 10:15 AM EST - 10 months ago

MDxHealth: Strong Buy On Its Cutting-Edge Urology Diagnostics

MDxHealth to Participate in Piper Sandler Healthcare Conference

Nov 25, 2024, 8:30 AM EST - 11 months ago

MDxHealth to Participate in Piper Sandler Healthcare Conference

MDxHealth SA (MDXH) Q3 2024 Earnings Call Transcript

Nov 8, 2024, 7:13 AM EST - 11 months ago

MDxHealth SA (MDXH) Q3 2024 Earnings Call Transcript

MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2024

Nov 6, 2024, 4:00 PM EST - 11 months ago

MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2024

MDxHealth Announces Pricing of Offering of Ordinary Shares

Sep 25, 2024, 9:31 PM EDT - 1 year ago

MDxHealth Announces Pricing of Offering of Ordinary Shares

MDxHealth Announces Launch of Offering of Ordinary Shares

Sep 25, 2024, 4:05 PM EDT - 1 year ago

MDxHealth Announces Launch of Offering of Ordinary Shares

MDxHealth SA (MDXH) Q2 2024 Earnings Call Transcript

Aug 22, 2024, 4:34 AM EDT - 1 year ago

MDxHealth SA (MDXH) Q2 2024 Earnings Call Transcript

MDxHealth Reports Q2 and Half Year 2024 Results

Aug 21, 2024, 4:00 PM EDT - 1 year ago

MDxHealth Reports Q2 and Half Year 2024 Results

MDxHealth to Present Second Quarter and First Half 2024 Financial Results and Corporate Update on August 21

Aug 12, 2024, 4:00 PM EDT - 1 year ago

MDxHealth to Present Second Quarter and First Half 2024 Financial Results and Corporate Update on August 21

MDxHealth Reports Preliminary Q2 and Half Year 2024 Revenues and Raises 2024 Revenue Guidance

Jul 8, 2024, 8:00 AM EDT - 1 year ago

MDxHealth Reports Preliminary Q2 and Half Year 2024 Revenues and Raises 2024 Revenue Guidance

Mdxhealth Appoints Sanford J. Siegel, M.D.

Jul 8, 2024, 8:00 AM EDT - 1 year ago

Mdxhealth Appoints Sanford J. Siegel, M.D.

Mdxhealth to Present at Upcoming Investor Conferences

May 15, 2024, 4:00 PM EDT - 1 year ago

Mdxhealth to Present at Upcoming Investor Conferences

MDxHealth SA (MDXH) Q1 2024 Earnings Call Transcript

May 4, 2024, 11:49 AM EDT - 1 year ago

MDxHealth SA (MDXH) Q1 2024 Earnings Call Transcript

MDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMed

May 1, 2024, 7:45 AM EDT - 1 year ago

MDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMed

Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering

Mar 12, 2024, 4:00 PM EDT - 1 year ago

Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering

MDxHealth SA (MDXH) Q4 2023 Earnings Call Transcript

Mar 6, 2024, 9:07 PM EST - 1 year ago

MDxHealth SA (MDXH) Q4 2023 Earnings Call Transcript

Mdxhealth Announces Fourth Quarter and Full-Year 2023 Financial Results

Mar 6, 2024, 4:00 PM EST - 1 year ago

Mdxhealth Announces Fourth Quarter and Full-Year 2023 Financial Results

MDxHealth to Present Fourth Quarter and Full Year 2023 Financial Results and Corporate Update on March 6

Feb 21, 2024, 5:00 PM EST - 1 year ago

MDxHealth to Present Fourth Quarter and Full Year 2023 Financial Results and Corporate Update on March 6

Mdxhealth Announces Resignation of Board Member

Feb 16, 2024, 8:45 AM EST - 1 year ago

Mdxhealth Announces Resignation of Board Member

MDxHealth Reports Preliminary Fourth Quarter and Full Year 2023 Revenues and Issues 2024 Revenue Guidance

Jan 8, 2024, 4:00 PM EST - 1 year ago

MDxHealth Reports Preliminary Fourth Quarter and Full Year 2023 Revenues and Issues 2024 Revenue Guidance

MDxHealth Announces Completion of Transition to Single Listing on Nasdaq

Dec 18, 2023, 1:00 AM EST - 1 year ago

MDxHealth Announces Completion of Transition to Single Listing on Nasdaq

MDxHealth Announces Completion of Mandatory ADS Exchange and Commencement of Transition Period to Single Listing on Nasdaq

Nov 27, 2023, 1:00 AM EST - 2 years ago

MDxHealth Announces Completion of Mandatory ADS Exchange and Commencement of Transition Period to Single Listing on Nasdaq

MDxHealth to Participate in the 35th Annual Piper Sandler Healthcare Conference

Nov 14, 2023, 4:00 PM EST - 2 years ago

MDxHealth to Participate in the 35th Annual Piper Sandler Healthcare Conference

MDxHealth SA (MXDHF) Q3 2023 Earnings Call Transcript

Nov 11, 2023, 5:33 PM EST - 2 years ago

MDxHealth SA (MXDHF) Q3 2023 Earnings Call Transcript

MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2023

Nov 8, 2023, 4:00 PM EST - 2 years ago

MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2023

MDxHealth Announces the Approval by its Shareholders of the Proposed Transition to a Sole Listing of Shares on Nasdaq, and Details of the Share Consolidation

Nov 6, 2023, 1:00 AM EST - 2 years ago

MDxHealth Announces the Approval by its Shareholders of the Proposed Transition to a Sole Listing of Shares on Nasdaq, and Details of the Share Consolidation

MDxHealth to Present Third Quarter 2023 Financial Results and Corporate Update on November 8

Oct 25, 2023, 4:00 PM EDT - 2 years ago

MDxHealth to Present Third Quarter 2023 Financial Results and Corporate Update on November 8

Mdxhealth's New Share Capital Amount and New Number of Shares

Oct 20, 2023, 4:00 PM EDT - 2 years ago

Mdxhealth's New Share Capital Amount and New Number of Shares

MDxHealth Reports Preliminary Q3-2023 Revenues

Oct 9, 2023, 4:00 PM EDT - 2 years ago

MDxHealth Reports Preliminary Q3-2023 Revenues

MDxHealth Announces Proposed Transition to a Sole Listing of Shares on Nasdaq and Convenes an Extraordinary General Shareholders Meeting

Oct 2, 2023, 4:04 PM EDT - 2 years ago

MDxHealth Announces Proposed Transition to a Sole Listing of Shares on Nasdaq and Convenes an Extraordinary General Shareholders Meeting

Mdxhealth Signs Research Collaboration with University of Oxford to Assess the Correlation of the GPS Test with Prostate Cancer Progression Following Treatment for Localized Prostate Cancer

Sep 26, 2023, 4:46 PM EDT - 2 years ago

Mdxhealth Signs Research Collaboration with University of Oxford to Assess the Correlation of the GPS Test with Prostate Cancer Progression Following Treatment for Localized Prostate Cancer

MDxHealth SA (MXDHF) Q2 2023 Earnings Call Transcript

Aug 23, 2023, 8:41 PM EDT - 2 years ago

MDxHealth SA (MXDHF) Q2 2023 Earnings Call Transcript

MDxHealth Reports Q2 and Half Year 2023 Results

Aug 23, 2023, 4:00 PM EDT - 2 years ago

MDxHealth Reports Q2 and Half Year 2023 Results

MDxHealth to Present Q2 and Half Year 2023 Financial Results and Corporate Update on August 23

Aug 10, 2023, 4:00 PM EDT - 2 years ago

MDxHealth to Present Q2 and Half Year 2023 Financial Results and Corporate Update on August 23

Cigna Expands Commercial and Medicare Advantage Coverage to Include Mdxhealth's Select mdx for Prostate Cancer Test

Aug 9, 2023, 4:00 PM EDT - 2 years ago

Cigna Expands Commercial and Medicare Advantage Coverage to Include Mdxhealth's Select mdx for Prostate Cancer Test

CI

MDxHealth Announces Results of its Extraordinary General Shareholders' Meeting

Jun 30, 2023, 4:00 PM EDT - 2 years ago

MDxHealth Announces Results of its Extraordinary General Shareholders' Meeting

MDxHealth Announces its Extraordinary General Shareholders' Meeting

Jun 5, 2023, 5:30 PM EDT - 2 years ago

MDxHealth Announces its Extraordinary General Shareholders' Meeting

MDxHealth Announces Results of its Annual and Extraordinary General Shareholders' Meetings

May 25, 2023, 4:30 PM EDT - 2 years ago

MDxHealth Announces Results of its Annual and Extraordinary General Shareholders' Meetings

MDxHealth to Present at the 43rd Annual William Blair Growth Stock Conference

May 23, 2023, 4:00 PM EDT - 2 years ago

MDxHealth to Present at the 43rd Annual William Blair Growth Stock Conference

MDxHealth SA (MXDHF) Q1 2023 Earnings Call Transcript

May 15, 2023, 9:24 PM EDT - 2 years ago

MDxHealth SA (MXDHF) Q1 2023 Earnings Call Transcript

MDxHealth Reports Q1-2023 Results

May 15, 2023, 4:00 PM EDT - 2 years ago

MDxHealth Reports Q1-2023 Results

MDxHealth to Present First Quarter 2023 Financial Results on May 15

May 1, 2023, 4:00 PM EDT - 2 years ago

MDxHealth to Present First Quarter 2023 Financial Results on May 15

MDxHealth Announces its Ordinary and Extraordinary General Shareholders' Meetings

Apr 25, 2023, 4:00 PM EDT - 2 years ago

MDxHealth Announces its Ordinary and Extraordinary General Shareholders' Meetings

livingthehilife
livingthehilife Oct. 3 at 5:08 PM
$SES 🧨 : Super low float under 50 million outstanding shares $MDXH a little more volume, and this thing will explode : $SPY
0 · Reply
NVDAMillionaire
NVDAMillionaire Oct. 2 at 6:17 AM
$MDXH Brilliant piece that captures MDXH's situation perfectly. So if you want to update your understanding of MDXH or get to know MDXH better, this is essential reading. https://beyondspx.com/quote/MDXH/analysis/mdxhealth-mdxh-unlocking-growth-in-urology-diagnostics-with-precision-technology
0 · Reply
slick3333
slick3333 Sep. 27 at 2:13 AM
$MDXH cant lie I was impressed with the recovery today!!
0 · Reply
Lukumon
Lukumon Sep. 26 at 6:02 PM
$MDXH $5 soon.
0 · Reply
highnihilism
highnihilism Sep. 25 at 12:36 PM
Volume (Relative to 90-Day Average) → $ADVM Adverum Biotechnologies × 2.7 $MDXH MdXHealth × 1.7 $IONR Ioneer × 12.8 $RICH Rchtech Robotics × 2.4 $TROX Tronox × 1.8
0 · Reply
slick3333
slick3333 Sep. 23 at 2:32 PM
$MDXH bummer it was a nice run while it lasted ….was hoping we crossed 5 before the dump oh well…..
2 · Reply
livingthehilife
livingthehilife Sep. 23 at 1:45 PM
$MDXH A push 2 5 Super low flot : $SPY
0 · Reply
slick3333
slick3333 Sep. 22 at 7:41 PM
$MDXH 3x normal volume what the volume is going on!
0 · Reply
thecontracap
thecontracap Sep. 22 at 3:25 PM
$MDXH 3.5x rev is $8. $4X rev is $9.50. $VCYT grows half as fast and trades 4.5x.
1 · Reply
livingthehilife
livingthehilife Sep. 22 at 2:46 PM
$MDXH : Super love float : $SPY
0 · Reply
slick3333
slick3333 Sep. 21 at 5:01 PM
$MDXH man 4 was a big break and I m halfway to break even! Yes I went in too heavy to make a difference to average down a few years back…..next areas to watch is to hold 4 and clean breaks of 4.50 and 5 …..it’s finally nice to see them bring profit and I was/am a little worried about the acquisition but it’s the only way for them to grow faster….those acquisitions always cost more money to develop and take longer to turn into positive income
0 · Reply
thingkfast
thingkfast Sep. 20 at 1:11 PM
$MDXH 👀
0 · Reply
Rice1122
Rice1122 Sep. 19 at 5:27 PM
$MDXH I think people are finally seeing this company’s potential with recent performance and the future direction of the management team. Naturally expect it to dip below 4$ again as people take profits but I have a feeling that this stock will reach 6-7$ by end of year
0 · Reply
slick3333
slick3333 Sep. 19 at 4:45 PM
$MDXH finally broke $4!!
0 · Reply
thecontracap
thecontracap Sep. 19 at 1:40 AM
$MDXH size-adjusted, $MDXH acquis of ExoDx is the best deal I’ve ever seen. Bio techne paid $250MM for it in 2018 before it even had reimbursement. Now it’s approved, generating $20MM+ of rev, growing 30% annually, and $MDXH bought it for… $5MM of stock and $10MM over the next 4 years?? Mgmt quality is everything in micro caps. Michael mcgarrity is a boss. $10 stock < 18 months
0 · Reply
livingthehilife
livingthehilife Sep. 18 at 3:37 PM
$MDXH : All we need is a little volume over here. This is A 💎 Super low float : $SPY $TQQQ $TNA
0 · Reply
thecontracap
thecontracap Sep. 15 at 10:23 PM
$MDXH deal closed. Great news. November update going to be epic.
0 · Reply
slick3333
slick3333 Sep. 11 at 11:36 PM
$MDXH strong day glad and new 52 week highs let’s break 4 and 4.25 and 5…..imagine with some big news and volume it would go nuts ….
0 · Reply
ChartMill
ChartMill Sep. 8 at 8:17 PM
Published a new swing trading setup today before market open - $MDXH - found via ChartMill's High Tight Flag Screener. This is how you do it: https://youtu.be/PjHwCxkBVOk
0 · Reply
slick3333
slick3333 Sep. 7 at 1:06 AM
$MDXH has held up well at 3.50 now decide which direction we go 2.50 or 4.50 next??
0 · Reply
livingthehilife
livingthehilife Aug. 27 at 10:46 PM
$SERV i’m not joking. I was the number fourth follower here buying this at $1.75.ish : Nobody was traded in it before the Nvidia news $NVDA : I’ve been buying this up for the last six months $MDXH on its way to six dollars
0 · Reply
slick3333
slick3333 Aug. 27 at 9:39 PM
$MDXH man it’s been a while….i definitely went to heavy in on this early on avg is 7.85….give me a miracle let me break even! Not sure how it will continue to keep momentum…..
0 · Reply